E P Winer Selected Research

E P Winer Research Topics

Disease

39	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2000
20	Neoplasms (Cancer) 10/2023 - 02/2000
12	Triple Negative Breast Neoplasms 10/2023 - 03/2011
3	Residual Neoplasm 10/2023 - 01/2017
3	Neoplasm Metastasis (Metastasis) 01/2019 - 11/2005
3	Cardiotoxicity 08/2001 - 01/2001
2	Brain Neoplasms (Brain Tumor) 10/2021 - 01/2020
2	Disease Progression 01/2020 - 03/2000
2	Leukemia 01/2017 - 02/2000
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Febrile Neutropenia 01/2019
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2017
1	Primary Ovarian Insufficiency 08/2015
1	Peripheral Nervous System Diseases (PNS Diseases) 08/2014
1	Obesity 05/2001
1	Weight Gain 05/2001
1	Body Weight (Weight, Body) 05/2001
1	Fatigue 03/2000
1	Conjunctivitis 03/2000
1	Carcinoma (Carcinomatosis) 02/2000

Drug/Important Bio-Agent (IBA)

10	Trastuzumab (Herceptin)FDA Link 12/2020 - 01/2001
6	Paclitaxel (Taxol)FDA LinkGeneric 12/2020 - 07/2013
6	Hormones (Hormone)IBA 11/2019 - 02/2000
5	AnthracyclinesIBA 01/2017 - 03/2000
4	130-nm albumin-bound paclitaxelIBA 12/2021 - 01/2020
4	atezolizumabIBA 12/2021 - 01/2020
4	Biomarkers (Surrogate Marker)IBA 11/2020 - 02/2012
3	Epidermal Growth Factor (EGF)IBA 10/2021 - 02/2013
3	human ERBB2 proteinIBA 12/2020 - 01/2012
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020 - 02/2012
3	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2001 - 01/2001
2	Circulating Tumor DNAIBA 10/2023 - 01/2020
2	B7-H1 AntigenIBA 01/2021 - 01/2020
2	APTIBA 12/2020 - 01/2019
2	Estrogen ReceptorsIBA 12/2020 - 02/2013
2	Cisplatin (Platino)FDA LinkGeneric 11/2020 - 03/2011
2	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 01/2020
2	Letrozole (Femara)FDA LinkGeneric 11/2019 - 01/2018
2	ribociclibIBA 11/2019 - 01/2018
2	Phenobarbital (Luminal)FDA Link 01/2019 - 02/2012
2	pembrolizumabIBA 01/2019 - 01/2019
2	Bevacizumab (Avastin)FDA Link 06/2013 - 03/2011
2	Vinorelbine (Navelbine)FDA LinkGeneric 06/2013 - 05/2001
2	Capecitabine (Xeloda)FDA Link 12/2012 - 10/2009
2	Cytotoxins (Cytolysins)IBA 08/2001 - 08/2001
1	TFXIBA 10/2023
1	abemaciclibIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 10/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 12/2020
1	Alanine Transaminase (SGPT)IBA 01/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	PlatinumIBA 01/2020
1	tucatinibIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Poly Adenosine Diphosphate RiboseIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2019
1	palbociclibIBA 01/2019
1	olaparibIBA 08/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	Diphosphonates (Bisphosphonates)IBA 01/2017
1	Protein Isoforms (Isoforms)IBA 01/2016
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2016
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 08/2015
1	ixabepilone (BMS 247550)FDA Link 07/2013
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 07/2013
1	tivozanibIBA 07/2013
1	Tyrosine Kinase InhibitorsIBA 07/2013
1	Methotrexate (Mexate)FDA LinkGeneric 02/2012
1	Fluorouracil (Carac)FDA LinkGeneric 02/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2012
1	Alkylating AgentsIBA 02/2012
1	Platinum Compounds (Compounds, Platinum)IBA 02/2012
1	Ado-Trastuzumab EmtansineIBA 01/2012
1	Gefitinib (Iressa)FDA Link 10/2009
1	Liposomes (Liposome)IBA 08/2001
1	Daunorubicin (Cerubidine)FDA LinkGeneric 08/2001
1	liposomal doxorubicin (Doxil)FDA Link 08/2001
1	N 30IBA 05/2001
1	Epirubicin (Ellence)FDA LinkGeneric 01/2001
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2000
1	Thalidomide (Thalomid)FDA Link 07/2000
1	Docetaxel (Taxotere)FDA Link 03/2000
1	Progesterone CongenersIBA 02/2000
1	Megestrol Acetate (Borea)FDA LinkGeneric 02/2000

Therapy/Procedure

24	Therapeutics 10/2021 - 03/2000
16	Drug Therapy (Chemotherapy) 12/2020 - 03/2000
5	Adjuvant Chemotherapy 01/2017 - 03/2000
4	Neoadjuvant Therapy 10/2023 - 03/2011
2	Radiotherapy 10/2021 - 09/2013
1	Combination Drug Therapy (Combination Chemotherapy) 02/2012
1	Aftercare (After-Treatment) 01/2012
1	Biological Therapy 08/2001
1	Resistance Training 05/2001
1	Drug Tapering 03/2000